Milestone Pharmaceuticals Inc.
MIST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $146,817 | $71,736 | $168,103 | $274,012 |
| - Cash | $25,314 | $13,760 | $7,636 | $114,141 |
| + Debt | $54,797 | $51,775 | $2,491 | $698 |
| Enterprise Value | $176,300 | $109,751 | $162,958 | $160,569 |
| Revenue | $0 | $1,000 | $5,000 | $15,000 |
| % Growth | -100% | -80% | -66.7% | – |
| Gross Profit | $0 | $1,000 | $5,000 | $15,000 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$37,833 | -$57,039 | -$58,299 | -$42,980 |
| % Margin | – | -5,703.9% | -1,166% | -286.5% |
| Net Income | -$41,519 | -$59,685 | -$58,388 | -$42,853 |
| % Margin | – | -5,968.5% | -1,167.8% | -285.7% |
| EPS Diluted | -0.67 | -1.39 | -1.35 | -1.02 |
| % Growth | 51.8% | -3% | -32.4% | – |
| Operating Cash Flow | -$28,848 | -$46,424 | -$52,469 | -$33,224 |
| Capital Expenditures | -$33 | -$112 | -$272 | $0 |
| Free Cash Flow | -$28,881 | -$46,536 | -$52,741 | -$33,224 |